Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
Haematologica
|
March 13, 2025
Safe platelet count for lumbar puncture: are we being overcautious?
Talha Badar
Expert Opinion on Investigational Drugs
|
April 10, 2021
Do histone deacytelase inhibitors and azacitidine combination hold potential as an effective treatment for high/very-high risk myelodysplastic syndromes?
Talha Badar, Ehab Atallah
Cancers
|
January 11, 2025
Role of Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia in the Contemporary Era
Omer Jamy, Talha Badar
Current Hematologic Malignancy Reports
|
July 5, 2022
Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms
Talha Badar, Timothy Chlon
Clinical Lymphoma, Myeloma & Leukemia
|
August 23, 2015
Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve Outcome
Talha Badar, Farhad Ravandi
Cancer Management and Research
|
December 30, 2022
Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes
Yenny Moreno Vanegas, Talha Badar
Current Treatment Options in Oncology
|
February 7, 2020
Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
Talha Badar, Nirav N Shah
Current Opinion in Hematology
|
January 7, 2026
Navigating prognostic stratification and approach to TP53-mutated myeloid neoplasms
Talha Badar, Ayalew Tefferi, Naseema Gangat
F1000Research
|
September 20, 2018
Recent advances in understanding and treating immunoglobulin light chain amyloidosis
Talha Badar, Anita D'Souza, Parameswaran Hari
Leukemia Research Reports
|
September 8, 2023
Aggressive chronic lymphocytic leukemia masked by extensive marrow fibrosis
Hareem Farooq, Ke Li, Talha Badar
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
Haematologica
|
March 13, 2025
Safe platelet count for lumbar puncture: are we being overcautious?
Talha Badar
Expert Opinion on Investigational Drugs
|
April 10, 2021
Do histone deacytelase inhibitors and azacitidine combination hold potential as an effective treatment for high/very-high risk myelodysplastic syndromes?
Talha Badar, Ehab Atallah
Cancers
|
January 11, 2025
Role of Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia in the Contemporary Era
Omer Jamy, Talha Badar
Current Hematologic Malignancy Reports
|
July 5, 2022
Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms
Talha Badar, Timothy Chlon
Clinical Lymphoma, Myeloma & Leukemia
|
August 23, 2015
Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve Outcome
Talha Badar, Farhad Ravandi
Cancer Management and Research
|
December 30, 2022
Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes
Yenny Moreno Vanegas, Talha Badar
Current Treatment Options in Oncology
|
February 7, 2020
Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
Talha Badar, Nirav N Shah
Current Opinion in Hematology
|
January 7, 2026
Navigating prognostic stratification and approach to TP53-mutated myeloid neoplasms
Talha Badar, Ayalew Tefferi, Naseema Gangat
F1000Research
|
September 20, 2018
Recent advances in understanding and treating immunoglobulin light chain amyloidosis
Talha Badar, Anita D'Souza, Parameswaran Hari
Leukemia Research Reports
|
September 8, 2023
Aggressive chronic lymphocytic leukemia masked by extensive marrow fibrosis
Hareem Farooq, Ke Li, Talha Badar
Page
of 12